Comparison |
| Alternate Manufacturer Number |
| | | 3796828 | 3796794 |
| Container Type |
Single-Dose Vial | Prefilled Syringe | Prefilled Syringe | Prefilled Syringe | Prefilled Syringe |
| Generic Drug Code |
16124 | 45103 | 45104 | 38082 | 38082 |
| Generic Drug Name |
Plerixafor | Filgrastim-aafi | Filgrastim-aafi | Filgrastim-sndz | Filgrastim-sndz |
| NDC Number |
70121169402 | 00069029101 | 00069029201 | 61314032610 | 61314032601 |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 180 days | McKesson Acceptable Dating: we will ship >= 180 days |
| Storage Requirements |
| Requires Refrigeration | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
| Strength |
20 mg / mL | 300 mcg / 0.5 mL | 480 mcg / 0.8 mL | 480 mcg / 0.8 mL | 480 mcg / 0.8 mL |
| Type |
Subcutaneous | Intravenous or Subcutaneous | Intravenous or Subcutaneous | Intravenous or Subcutaneous | Intravenous or Subcutaneous |
| UNSPSC Code |
51131520 | 51201802 | 51201802 | 51201802 | 51201802 |
| Volume |
1.2 mL | 0.5 mL | 0.8 mL | 0.8 mL | 0.8 mL |
| Application |
Hematopoietic Agent | Hematopoietic Agent | Hematopoietic Agent | Hematopoietic Agent | Hematopoietic Agent |
| Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Features and Benefits |
- Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma
|
|
|
|
|
